CymaBay Therapeutics Inc. (CBAY) Social Stream

Featured Post From StockTwits About CBAY

$CBAY Focused on Seladelpar. Increase in expenses due to prep for launch of Seladelpar. Recent funding is specifically to get the drug “across the finish line”. They had many available options for capital and considered share holder value when making the decision. Covid delays likely to continue only negative I heard. Going to hold an analyst day in November. I’m going to keep accumulating cheap shares.